The physiology of brain histamine - PubMed
Review
The physiology of brain histamine
R E Brown et al. Prog Neurobiol. 2001 Apr.
Abstract
Histamine-releasing neurons are located exclusively in the TM of the hypothalamus, from where they project to practically all brain regions, with ventral areas (hypothalamus, basal forebrain, amygdala) receiving a particularly strong innervation. The intrinsic electrophysiological properties of TM neurons (slow spontaneous firing, broad action potentials, deep after hyperpolarisations, etc.) are extremely similar to other aminergic neurons. Their firing rate varies across the sleep-wake cycle, being highest during waking and lowest during rapid-eye movement sleep. In contrast to other aminergic neurons somatodendritic autoreceptors (H3) do not activate an inwardly rectifying potassium channel but instead control firing by inhibiting voltage-dependent calcium channels. Histamine release is enhanced under extreme conditions such as dehydration or hypoglycemia or by a variety of stressors. Histamine activates four types of receptors. H1 receptors are mainly postsynaptically located and are coupled positively to phospholipase C. High densities are found especially in the hypothalamus and other limbic regions. Activation of these receptors causes large depolarisations via blockade of a leak potassium conductance, activation of a non-specific cation channel or activation of a sodium-calcium exchanger. H2 receptors are also mainly postsynaptically located and are coupled positively to adenylyl cyclase. High densities are found in hippocampus, amygdala and basal ganglia. Activation of these receptors also leads to mainly excitatory effects through blockade of calcium-dependent potassium channels and modulation of the hyperpolarisation-activated cation channel. H3 receptors are exclusively presynaptically located and are negatively coupled to adenylyl cyclase. High densities are found in the basal ganglia. These receptors mediated presynaptic inhibition of histamine release and the release of other neurotransmitters, most likely via inhibition of presynaptic calcium channels. Finally, histamine modulates the glutamate NMDA receptor via an action at the polyamine binding site. The central histamine system is involved in many central nervous system functions: arousal; anxiety; activation of the sympathetic nervous system; the stress-related release of hormones from the pituitary and of central aminergic neurotransmitters; antinociception; water retention and suppression of eating. A role for the neuronal histamine system as a danger response system is proposed.
Similar articles
-
Identification of histaminergic neurons through histamine 3 receptor-mediated autoinhibition.
De Luca R, Suvorava T, Yang D, Baumgärtel W, Kojda G, Haas HL, Sergeeva OA. De Luca R, et al. Neuropharmacology. 2016 Jul;106:102-15. doi: 10.1016/j.neuropharm.2015.08.025. Epub 2015 Aug 19. Neuropharmacology. 2016. PMID: 26297536
-
Histamine in the nervous system.
Haas HL, Sergeeva OA, Selbach O. Haas HL, et al. Physiol Rev. 2008 Jul;88(3):1183-241. doi: 10.1152/physrev.00043.2007. Physiol Rev. 2008. PMID: 18626069 Review.
-
Vanni-Mercier G, Gigout S, Debilly G, Lin JS. Vanni-Mercier G, et al. Behav Brain Res. 2003 Sep 15;144(1-2):227-41. doi: 10.1016/s0166-4328(03)00091-3. Behav Brain Res. 2003. PMID: 12946612
-
Glutamate Activates the Histaminergic Tuberomammillary Nucleus and Increases Wakefulness in Rats.
Yin D, Dong H, Wang TX, Hu ZZ, Cheng NN, Qu WM, Huang ZL. Yin D, et al. Neuroscience. 2019 Aug 10;413:86-98. doi: 10.1016/j.neuroscience.2019.05.032. Epub 2019 Jun 14. Neuroscience. 2019. PMID: 31202706
-
Presynaptic receptors for dopamine, histamine, and serotonin.
Feuerstein TJ. Feuerstein TJ. Handb Exp Pharmacol. 2008;(184):289-338. doi: 10.1007/978-3-540-74805-2_10. Handb Exp Pharmacol. 2008. PMID: 18064418 Review.
Cited by
-
Gondard E, Anaclet C, Akaoka H, Guo RX, Zhang M, Buda C, Franco P, Kotani H, Lin JS. Gondard E, et al. Neuropsychopharmacology. 2013 May;38(6):1015-31. doi: 10.1038/npp.2012.266. Epub 2013 Jan 2. Neuropsychopharmacology. 2013. PMID: 23303066 Free PMC article.
-
Torrealba F, Riveros ME, Contreras M, Valdes JL. Torrealba F, et al. Front Syst Neurosci. 2012 Jul 4;6:51. doi: 10.3389/fnsys.2012.00051. eCollection 2012. Front Syst Neurosci. 2012. PMID: 22783171 Free PMC article.
-
Chang SY, Jay T, Muñoz J, Kim I, Lee KH. Chang SY, et al. Analyst. 2012 May 7;137(9):2158-65. doi: 10.1039/c2an16038b. Epub 2012 Mar 14. Analyst. 2012. PMID: 22416270 Free PMC article.
-
Kholdebarin E, Caldwell DP, Blackwelder WP, Kao M, Christopher NC, Levin ED. Kholdebarin E, et al. Eur J Pharmacol. 2007 Aug 13;569(1-2):64-9. doi: 10.1016/j.ejphar.2007.04.051. Epub 2007 May 22. Eur J Pharmacol. 2007. PMID: 17544392 Free PMC article.
-
Kuo KT, Lin CH, Wang CH, Pikatan NW, Yadav VK, Fong IH, Yeh CT, Lee WH, Huang WC. Kuo KT, et al. Int J Mol Sci. 2022 Jan 31;23(3):1663. doi: 10.3390/ijms23031663. Int J Mol Sci. 2022. PMID: 35163585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources